Synthesis and pharmacological properties of 4(5)-(2-ethyl-2,3-dihydro-2 silainden-2-yl)imidazole, a silicon analogue of atipamezole
4(5)-(2-Ethyl-2,3-dihydro-2-silainden-2-yl)imidazole 2a, 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)imidazole 2b and 4(5)-(2-ethyl-2,3-dihydro-2-silainden-2-yl)-2-methylimidazole 2c, C2 silicon analogues of the commercially available α 2-adrenergic receptor antagonist atipamezole 1, were prepared a...
Saved in:
Published in | European journal of medicinal chemistry Vol. 31; no. 9; pp. 725 - 729 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
PARIS CEDEX 15
Elsevier Masson SAS
1996
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | 4(5)-(2-Ethyl-2,3-dihydro-2-silainden-2-yl)imidazole
2a, 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)imidazole
2b and 4(5)-(2-ethyl-2,3-dihydro-2-silainden-2-yl)-2-methylimidazole
2c, C2 silicon analogues of the commercially available α
2-adrenergic receptor antagonist atipamezole
1, were prepared and their pharmacological properties were evaluated. The results show that
2a retained significant affinity for the receptors, and the in vivo pharmacokinetic properties of
2a were comparable to those of
1. |
---|---|
AbstractList | 4(5)-(2-Ethyl-2,3-dihydro-2-silainden-2-yl)imidazole 2a, 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)imidazole 2b and 4(5)-(2-ethyl-2,3-dihydro-2-silainden-2-yl)-2-methylimidazole 2c, C2 silicon analogues of the commercially available alpha(2)-adrenergic receptor antagonist atipamezole 1, were prepared and their pharmacological properties were evaluated. The results show that 2a retained significant affinity for the receptors, and the in vivo pharmacokinetic properties of 2a were comparable to those of 1. 4(5)-(2-Ethyl-2,3-dihydro-2-silainden-2-yl)imidazole 2a, 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)imidazole 2b and 4(5)-(2-ethyl-2,3-dihydro-2-silainden-2-yl)-2-methylimidazole 2c, C2 silicon analogues of the commercially available α 2-adrenergic receptor antagonist atipamezole 1, were prepared and their pharmacological properties were evaluated. The results show that 2a retained significant affinity for the receptors, and the in vivo pharmacokinetic properties of 2a were comparable to those of 1. |
Author | Lönnberg, H Cockcroft, VB Sipilä, H Savola, JM Neuvonen, K Salonen, JS Wurster, S Heinonen, P Virtanen, R Savola, MKT |
Author_xml | – sequence: 1 givenname: P surname: Heinonen fullname: Heinonen, P organization: Department of Chemistry, University of Turku, 20500 Turku, Finland – sequence: 2 givenname: H surname: Sipilä fullname: Sipilä, H organization: Turku Medical PET-Center/TUCH, 20520 Turku, Finland – sequence: 3 givenname: K surname: Neuvonen fullname: Neuvonen, K organization: Department of Chemistry, University of Turku, 20500 Turku, Finland – sequence: 4 givenname: H surname: Lönnberg fullname: Lönnberg, H email: harri.lonnberg@utu.fi organization: Department of Chemistry, University of Turku, 20500 Turku, Finland – sequence: 5 givenname: VB surname: Cockcroft fullname: Cockcroft, VB organization: Orion Corporation, Orion-Farmos, Farmos Research, PO Box 425, 20101 Turku, Finland – sequence: 6 givenname: S surname: Wurster fullname: Wurster, S organization: Orion Corporation, Orion-Farmos, Farmos Research, PO Box 425, 20101 Turku, Finland – sequence: 7 givenname: R surname: Virtanen fullname: Virtanen, R organization: Orion Corporation, Orion-Farmos, Farmos Research, PO Box 425, 20101 Turku, Finland – sequence: 8 givenname: MKT surname: Savola fullname: Savola, MKT organization: Orion Corporation, Orion-Farmos, Farmos Research, PO Box 425, 20101 Turku, Finland – sequence: 9 givenname: JS surname: Salonen fullname: Salonen, JS – sequence: 10 givenname: JM surname: Savola fullname: Savola, JM organization: Orion Corporation, Orion-Farmos, Farmos Research, PO Box 425, 20101 Turku, Finland |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3190661$$DView record in Pascal Francis |
BookMark | eNqNkD9v1DAYhy1UJK4t34AhA8OdqFv_i5MsSNUJKFIlhgLqZjn2a84oZ0d2Cgprv3gdrroRMXnw8_wsP6foJMQACL2h5JISKq8IYxzXjIt1Jzdt3bYM379AK9rIFnNWixO0OiKv0GnOPwkhtSRkhR7v5jDtIPtc6WCrcafTXps4xB_e6KEaUxwhTR5yFV0l1vUGrxmGaTcPmF1wbP1utiliVmU_aB8sBMzwPGz83lv9Jw5wUenlzpsYygu6DD_AsqUnP-o9LMg5eun0kOH183mGvn388HV7g2-_fPq8vb7FhtfthIWxTSsYaZygDAzTnPAeOseNFZb1PZOta2RHGtPpuoamF60hnDqQzMqaMn6GxGHXpJhzAqfG5Pc6zYoStYRUSyW1VFKdVH9DqvuivT1oo86liUs6GJ-PLqcdkZIWrD1gv6GPLhsPwcCRuqZdJ7_fkAITQsnWTyVADNv4EKaivvt_tdDvDzSUVr88JPVsWJ_ATMpG_-8PPQHHLqpO |
CODEN | EJMCA5 |
CitedBy_id | crossref_primary_10_1016_j_bmc_2015_01_046 crossref_primary_10_1021_acs_orglett_9b00326 crossref_primary_10_1016_S1359_6446_03_02726_0 crossref_primary_10_1002_ejoc_201700198 crossref_primary_10_1007_s11426_019_9528_2 crossref_primary_10_1021_jm1006269 crossref_primary_10_1021_ol302040j crossref_primary_10_1002_chin_199652145 crossref_primary_10_1016_j_scp_2020_100331 crossref_primary_10_1002_ejoc_200801197 |
Cites_doi | 10.1016/0167-4889(92)90041-9 10.1002/jhet.5570220115 10.1016/S0021-9258(17)43021-3 10.1016/0160-9327(86)90093-1 10.1016/0160-5402(85)90034-8 10.1021/jo00020a002 10.1002/jcc.540100208 10.1016/0922-4106(93)90034-7 10.1016/0014-2999(91)90535-X |
ContentType | Journal Article |
Copyright | 1996 Elsevier, Paris 1996 INIST-CNRS |
Copyright_xml | – notice: 1996 Elsevier, Paris – notice: 1996 INIST-CNRS |
DBID | 1KM BLEPL DTL FCAKS IQODW AAYXX CITATION |
DOI | 10.1016/0223-5234(96)85882-X |
DatabaseName | Index Chemicus Web of Science Core Collection Science Citation Index Expanded Web of Science - Science Citation Index Expanded - 1996 Pascal-Francis CrossRef |
DatabaseTitle | Web of Science CrossRef |
DatabaseTitleList | Web of Science |
Database_xml | – sequence: 1 dbid: 1KM name: Index Chemicus url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC sourceTypes: Enrichment Source Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1768-3254 |
EndPage | 729 |
ExternalDocumentID | 10_1016_0223_5234_96_85882_X 3190661 A1996VH01900010 022352349685882X |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 29G 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM 9JN AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARLI AATCM AAXUO AAYOK ABFNM ABFRF ABGSF ABJNI ABMAC ABOCM ABUDA ABXDB ABYKQ ABZDS ACDAQ ACGFO ACIUM ACNNM ACRLP ADBBV ADECG ADEZE ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AFZHZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJSZI ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FLBIZ FNPLU FYGXN G-2 G-Q GBLVA HMS HMT HVGLF HZ~ IHE J1W KOM M2Y M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCB SCC SDF SDG SES SEW SOC SPC SPCBC SPT SSK SSP SSU SSZ T5K WUQ ~G- 1KM AAXKI AKRWK BLEPL DTL GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED AAPBV ABPIF ABPTK IQODW AAYXX AFJKZ CITATION |
ID | FETCH-LOGICAL-c358t-4cd784207f412ec2a303be9f3cd4d2bb268f76907c9a55e7b48c031fe62d65123 |
IEDL.DBID | .~1 |
ISICitedReferencesCount | 14 |
ISICitedReferencesURI | https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=A1996VH01900010 |
ISSN | 0223-5234 |
IngestDate | Thu Sep 26 17:36:55 EDT 2024 Sun Oct 29 17:08:35 EDT 2023 Fri Nov 08 20:04:54 EST 2024 Wed Sep 18 06:08:54 EDT 2024 Fri Feb 23 02:16:50 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | silaindane adrenergic receptor Grignard reaction atipamezole semi-empirical calculation ALPHA-2-ADRENOCEPTORS BINDING Human α2-Adrenergic receptor Imidazole derivatives Silicon heterocycle Rat Nitrogen heterocycle Rodentia In vitro In vivo Vertebrata Biological fixation Mammalia Structure activity relation Animal Affinity Subcutaneous administration Antagonist Pharmacokinetics Chemical synthesis |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
LogoURL | https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg |
MergedId | FETCHMERGED-LOGICAL-c358t-4cd784207f412ec2a303be9f3cd4d2bb268f76907c9a55e7b48c031fe62d65123 |
PageCount | 5 |
ParticipantIDs | pascalfrancis_primary_3190661 webofscience_primary_A1996VH01900010CitationCount elsevier_sciencedirect_doi_10_1016_0223_5234_96_85882_X crossref_primary_10_1016_0223_5234_96_85882_X webofscience_primary_A1996VH01900010 |
PublicationCentury | 1900 |
PublicationDate | 1996 1996-01-01 1996-1-00 |
PublicationDateYYYYMMDD | 1996-01-01 |
PublicationDate_xml | – year: 1996 text: 1996 |
PublicationDecade | 1990 |
PublicationPlace | PARIS CEDEX 15 |
PublicationPlace_xml | – name: PARIS CEDEX 15 – name: Oxford |
PublicationTitle | European journal of medicinal chemistry |
PublicationTitleAbbrev | EUR J MED CHEM |
PublicationYear | 1996 |
Publisher | Elsevier Masson SAS Elsevier |
Publisher_xml | – name: Elsevier Masson SAS – name: Elsevier |
References | Karjalainen AJ, Virtanen RE, Karjalainen AL, Kurkela KOA (1987) US Patent 4,689,339 Stewart (bib3) 1989; 10 Arunlakshana, Schild (bib11) 1959; 14 Marjamäki, Ala-Uotila, Luomala, Perälä, Jansson, Jalkanen, Regan, Scheinin (bib7) 1992; 1134 Nametkin, Vdodin, Finkel'Shtein, Arkhipov, Oppengein (bib5) 1964; 154 Corriu, Henner, Massé (bib6) 1968 Halle, Pichon, Terrier (bib14) 1984; 259 (bib12) 1982 Turner, Lindell (bib4) 1991; 56 Marjamäki, Luomala, Ala-Uotila, Scheinin (bib8) 1993; 246 Savola, Virtanen (bib9) 1991; 195 McPherson (bib15) 1985; 14 Virtanen, Savola, Saano (bib10) 1989; 297 Kirk (bib13) 1985; 22 Tacke, Zilch (bib2) 1986; 10 CORRIU, R (WOS:A1968B529300068) 1968 MCPHERSON, GA (WOS:A1985ARP0300006) 1985; 14 (WOS:A1996VH01900010.1) 1987 MARJAMAKI, A (WOS:A1992HM55400011) 1992; 1134 HALLE, JC (WOS:A1984SL48600023) 1984; 259 NAMETKIN NS (WOS:A1996VH01900010.10) 1964; 154 ARUNLAKSHANA, O (WOS:A1959WT10300009) 1959; 14 TURNER, RM (WOS:A1991GH36900002) 1991; 56 STEWART, JJP (WOS:A1989T690100007) 1989; 10 CRC (WOS:A1996VH01900010.2) 1982 TACKE, R (WOS:A1986F434500006) 1986; 10 SAVOLA, JM (WOS:A1991FG22900002) 1991; 195 MARJAMAKI, A (WOS:A1993LV61300005) 1993; 246 VIRTANEN, R (WOS:A1989T500700017) 1989; 297 KIRK, KL (WOS:A1985ACW2300015) 1985; 22 Turner (10.1016/0223-5234(96)85882-X_bib4) 1991; 56 Savola (10.1016/0223-5234(96)85882-X_bib9) 1991; 195 (10.1016/0223-5234(96)85882-X_bib12) 1982 Halle (10.1016/0223-5234(96)85882-X_bib14) 1984; 259 Stewart (10.1016/0223-5234(96)85882-X_bib3) 1989; 10 Tacke (10.1016/0223-5234(96)85882-X_bib2) 1986; 10 Nametkin (10.1016/0223-5234(96)85882-X_bib5) 1964; 154 Marjamäki (10.1016/0223-5234(96)85882-X_bib8) 1993; 246 McPherson (10.1016/0223-5234(96)85882-X_bib15) 1985; 14 Marjamäki (10.1016/0223-5234(96)85882-X_bib7) 1992; 1134 10.1016/0223-5234(96)85882-X_bib1 Virtanen (10.1016/0223-5234(96)85882-X_bib10) 1989; 297 Corriu (10.1016/0223-5234(96)85882-X_bib6) 1968 Arunlakshana (10.1016/0223-5234(96)85882-X_bib11) 1959; 14 Kirk (10.1016/0223-5234(96)85882-X_bib13) 1985; 22 |
References_xml | – volume: 154 start-page: 383 year: 1964 end-page: 386 ident: bib5 publication-title: Dolk Akad Nau SSSR contributor: fullname: Oppengein – volume: 14 start-page: 48 year: 1959 end-page: 58 ident: bib11 publication-title: Br J Parmacol contributor: fullname: Schild – start-page: 3013 year: 1968 end-page: 3023 ident: bib6 publication-title: Bull Soc Chim Fr contributor: fullname: Massé – volume: 259 start-page: 4142 year: 1984 end-page: 4146 ident: bib14 publication-title: J Biol Chem contributor: fullname: Terrier – volume: 10 start-page: 191 year: 1986 end-page: 197 ident: bib2 publication-title: contributor: fullname: Zilch – year: 1982 ident: bib12 publication-title: Handbook of Chemistry and Physics – volume: 1134 start-page: 169 year: 1992 end-page: 177 ident: bib7 publication-title: Biochem Biophys Acta contributor: fullname: Scheinin – volume: 14 start-page: 213 year: 1985 end-page: 228 ident: bib15 publication-title: J Pharmacol Methods contributor: fullname: McPherson – volume: 10 start-page: 209 year: 1989 end-page: 220 ident: bib3 publication-title: J Comp Chem contributor: fullname: Stewart – volume: 22 start-page: 57 year: 1985 end-page: 59 ident: bib13 publication-title: J Heterocycl Chem contributor: fullname: Kirk – volume: 195 start-page: 193 year: 1991 end-page: 199 ident: bib9 publication-title: Eur J Pharmacol contributor: fullname: Virtanen – volume: 297 start-page: 190 year: 1989 end-page: 204 ident: bib10 publication-title: Arch Int Pharmacodyn Ther contributor: fullname: Saano – volume: 246 start-page: 219 year: 1993 end-page: 226 ident: bib8 publication-title: Eur J Pharmacol contributor: fullname: Scheinin – volume: 56 start-page: 5739 year: 1991 end-page: 5740 ident: bib4 publication-title: J Org Chem contributor: fullname: Lindell – volume: 14 start-page: 213 year: 1985 ident: WOS:A1985ARP0300006 article-title: ANALYSIS OF RADIOLIGAND BINDING EXPERIMENTS - A COLLECTION OF COMPUTER-PROGRAMS FOR THE IBM-PC publication-title: JOURNAL OF PHARMACOLOGICAL METHODS contributor: fullname: MCPHERSON, GA – volume: 22 start-page: 57 year: 1985 ident: WOS:A1985ACW2300015 article-title: 4-LITHIO-1-TRITYLIMIDAZOLE AS A SYNTHETIC INTERMEDIATE - SYNTHESIS OF IMIDAZOLE-4-CARBOXALDEHYDE publication-title: JOURNAL OF HETEROCYCLIC CHEMISTRY contributor: fullname: KIRK, KL – volume: 259 start-page: 4142 year: 1984 ident: WOS:A1984SL48600023 article-title: SOLVENT EFFECT ON THE PROTON-BINDING SITES IN UROCANIC ACID - A TAUTOMERIC EQUILIBRIUM STUDY publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY contributor: fullname: HALLE, JC – volume: 56 start-page: 5739 year: 1991 ident: WOS:A1991GH36900002 article-title: A FACILE ROUTE TO IMIDAZOL-4-YL ANIONS AND THEIR REACTION WITH CARBONYL-COMPOUNDS publication-title: JOURNAL OF ORGANIC CHEMISTRY contributor: fullname: TURNER, RM – volume: 195 start-page: 193 year: 1991 ident: WOS:A1991FG22900002 article-title: CENTRAL ALPHA-2-ADRENOCEPTORS ARE HIGHLY STEREOSELECTIVE FOR DEXMEDETOMIDINE, THE DEXTRO ENANTIOMER OF MEDETOMIDINE publication-title: EUROPEAN JOURNAL OF PHARMACOLOGY contributor: fullname: SAVOLA, JM – volume: 154 start-page: 383 year: 1964 ident: WOS:A1996VH01900010.10 publication-title: COKL AKAD NAU SSSR contributor: fullname: NAMETKIN NS – year: 1987 ident: WOS:A1996VH01900010.1 – volume: 297 start-page: 190 year: 1989 ident: WOS:A1989T500700017 article-title: HIGHLY SELECTIVE AND SPECIFIC ANTAGONISM OF CENTRAL AND PERIPHERAL ALPHA-2-ADRENOCEPTORS BY ATIPAMEZOLE publication-title: ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE contributor: fullname: VIRTANEN, R – start-page: 3013 year: 1968 ident: WOS:A1968B529300068 article-title: PREPARATION AND CYCLISATION OF VINYL AND CHLOROMETHYL SILANES publication-title: BULLETIN DE LA SOCIETE CHIMIQUE DE FRANCE contributor: fullname: CORRIU, R – volume: 246 start-page: 219 year: 1993 ident: WOS:A1993LV61300005 article-title: USE OF RECOMBINANT HUMAN ALPHA(2)-ADRENOCEPTORS TO CHARACTERIZE SUBTYPE SELECTIVITY OF ANTAGONIST BINDING publication-title: EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION contributor: fullname: MARJAMAKI, A – volume: 1134 start-page: 169 year: 1992 ident: WOS:A1992HM55400011 article-title: STABLE EXPRESSION OF RECOMBINANT HUMAN ALPHA-2-ADRENOCEPTOR SUBTYPES IN 2 MAMMALIAN-CELL LINES - CHARACTERIZATION WITH [H-3] RAUWOLSCINE BINDING, INHIBITION OF ADENYLATE-CYCLASE AND RNASE PROTECTION ASSAY publication-title: BIOCHIMICA ET BIOPHYSICA ACTA contributor: fullname: MARJAMAKI, A – volume: 10 start-page: 191 year: 1986 ident: WOS:A1986F434500006 article-title: SILA-SUBSTITUTION - A USEFUL STRATEGY FOR DRUG DESIGN publication-title: ENDEAVOUR contributor: fullname: TACKE, R – year: 1982 ident: WOS:A1996VH01900010.2 publication-title: HDB CHEM PHYS contributor: fullname: CRC – volume: 10 start-page: 209 year: 1989 ident: WOS:A1989T690100007 article-title: OPTIMIZATION OF PARAMETERS FOR SEMIEMPIRICAL METHODS .1. METHOD publication-title: JOURNAL OF COMPUTATIONAL CHEMISTRY contributor: fullname: STEWART, JJP – volume: 14 start-page: 48 year: 1959 ident: WOS:A1959WT10300009 article-title: SOME QUANTITATIVE USES OF DRUG ANTAGONISTS publication-title: BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY contributor: fullname: ARUNLAKSHANA, O – volume: 297 start-page: 190 year: 1989 ident: 10.1016/0223-5234(96)85882-X_bib10 publication-title: Arch Int Pharmacodyn Ther contributor: fullname: Virtanen – volume: 1134 start-page: 169 year: 1992 ident: 10.1016/0223-5234(96)85882-X_bib7 publication-title: Biochem Biophys Acta doi: 10.1016/0167-4889(92)90041-9 contributor: fullname: Marjamäki – volume: 14 start-page: 48 year: 1959 ident: 10.1016/0223-5234(96)85882-X_bib11 publication-title: Br J Parmacol contributor: fullname: Arunlakshana – volume: 22 start-page: 57 year: 1985 ident: 10.1016/0223-5234(96)85882-X_bib13 publication-title: J Heterocycl Chem doi: 10.1002/jhet.5570220115 contributor: fullname: Kirk – volume: 259 start-page: 4142 year: 1984 ident: 10.1016/0223-5234(96)85882-X_bib14 publication-title: J Biol Chem doi: 10.1016/S0021-9258(17)43021-3 contributor: fullname: Halle – volume: 10 start-page: 191 year: 1986 ident: 10.1016/0223-5234(96)85882-X_bib2 publication-title: Endeavour, New Series doi: 10.1016/0160-9327(86)90093-1 contributor: fullname: Tacke – volume: 14 start-page: 213 year: 1985 ident: 10.1016/0223-5234(96)85882-X_bib15 publication-title: J Pharmacol Methods doi: 10.1016/0160-5402(85)90034-8 contributor: fullname: McPherson – volume: 56 start-page: 5739 year: 1991 ident: 10.1016/0223-5234(96)85882-X_bib4 publication-title: J Org Chem doi: 10.1021/jo00020a002 contributor: fullname: Turner – volume: 154 start-page: 383 year: 1964 ident: 10.1016/0223-5234(96)85882-X_bib5 publication-title: Dolk Akad Nau SSSR contributor: fullname: Nametkin – ident: 10.1016/0223-5234(96)85882-X_bib1 – volume: 10 start-page: 209 year: 1989 ident: 10.1016/0223-5234(96)85882-X_bib3 publication-title: J Comp Chem doi: 10.1002/jcc.540100208 contributor: fullname: Stewart – volume: 246 start-page: 219 year: 1993 ident: 10.1016/0223-5234(96)85882-X_bib8 publication-title: Eur J Pharmacol doi: 10.1016/0922-4106(93)90034-7 contributor: fullname: Marjamäki – year: 1982 ident: 10.1016/0223-5234(96)85882-X_bib12 – volume: 195 start-page: 193 year: 1991 ident: 10.1016/0223-5234(96)85882-X_bib9 publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(91)90535-X contributor: fullname: Savola – start-page: 3013 year: 1968 ident: 10.1016/0223-5234(96)85882-X_bib6 publication-title: Bull Soc Chim Fr contributor: fullname: Corriu |
SSID | ssj0005600 |
Score | 1.5940189 |
Snippet | 4(5)-(2-Ethyl-2,3-dihydro-2-silainden-2-yl)imidazole
2a, 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)imidazole
2b and... 4(5)-(2-Ethyl-2,3-dihydro-2-silainden-2-yl)imidazole 2a, 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)imidazole 2b and... |
Source | Web of Science |
SourceID | crossref pascalfrancis webofscience elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 725 |
SubjectTerms | adrenergic receptor atipamezole Biological and medical sciences Catecholaminergic system Chemistry, Medicinal Grignard reaction Life Sciences & Biomedicine Medical sciences Neuropharmacology Neurotransmitters. Neurotransmission. Receptors Pharmacology & Pharmacy Pharmacology. Drug treatments Science & Technology semi-empirical calculation silaindane |
Title | Synthesis and pharmacological properties of 4(5)-(2-ethyl-2,3-dihydro-2 silainden-2-yl)imidazole, a silicon analogue of atipamezole |
URI | https://dx.doi.org/10.1016/0223-5234(96)85882-X http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=A1996VH01900010 |
Volume | 31 |
WOS | A1996VH01900010 |
WOSCitedRecordID | wosA1996VH01900010 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pi9QwFA6yHhREdFUcdZcclmUGJo5N07Q9LoPLqLgsuCu9lfxkC7OdMh0P9eDFf9z3-mNmFhTFa5M2Id_re98LeV8IOYkC74EZOxYb55mIpWI6TQTzHBJsbkJpAiwU_nwhF9fiYxZle7UweKyy9_2dT2-9df9k1q_mrCqKGQQfIA-od55EQBMzLGCH6Acm_fbH3ikP2VWhQGfMucRQPRfI2fbZOJWT9hss-1N0elSpGtbMd5dd_DZItQHp_Al53DNJetZN9im558pD8mA-XOB2SE4vO1nqZkqvdlVW9ZSe0sudYHXzjPz80pTAA-uipqq0tNo1IoK0wv36NQqv0pWnYhxN2JgzBwgvGZ-GzBY3jV2vGKd1sVQov1gyzprlpLgtrPq-WropVdgGRlfCCN12EX4LrKJStw67PCfX5--v5gvWX87ATBglGyaMjRPB38VeBNwZriAWapf60FhhudZcJj7G1NukKopcrEViwIF4J7mVwDLCF-SgXJXuJaER2INNJHROjFCR1tLKVEAeEwNZ0qkYETaAkledBkc-HE5DEHMEMU9l3oKYZyMSD8jld2wphzDxlzeP7gC9HQ4cFXCzYERO9oHfNqN2sPy6wLp8TLJHJPiXbvNehR3VBzav_nvSr8nD7ig57gu9IQeb9Td3BExpo4_bf-GY3D_78Glx8QuXRw4D |
link.rule.ids | 315,783,787,4031,4509,24128,27935,27936,27937,45597,45691 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFLZgHIaEEAwQBQY-TFMr1ZQ4jpMcUcVUYJsm0aHcIsc_tEhdGjXdITtw4R_nvfxoOwkE4ho7seXv5b3vWX6fCTkKPOeAGVsWauuYCKViWRwJ5jgk2Fz7UntYKHx2LmeX4ksSJDu1MHissvP9rU9vvHX3ZNKt5qTM8wkEHyAPqHceBUATk_vkgUB6DDb9_sfOMQ_ZlqFAb0y6RF8-58nJ5tkwlqPmIyz5U3h6VKoKFs21t138Nko1EenkCXncUUn6sZ3tU3LPFgdkf9rf4HZAji9aXep6TOfbMqtqTI_pxVaxun5Gfn6rCyCCVV5RVRhabhsRQlrihv0KlVfp0lExDEZsyJkFiBeMj31m8qvarJaM0ypfKNRfLBhn9WKUX-dG3S4XdkwVtoHVFTBCu1-E3wKzKNW1xS7PyeXJp_l0xrrbGZj2g2jNhDZhJPiH0AmPW80VBMPMxs7XRhieZVxGLsTcW8cqCGyYiUiDB3FWciOBZvgvyF6xLOxLQgMwCBNJ6BxpoYIsk0bGAhKZENhSFosBYT0oadmKcKT96TQEMUUQ01imDYhpMiBhj1x6x5hSiBN_efPwDtCb4cBTATnzBuRoF_hNM4oHy-8zLMzHLHtAvH_pNu1k2FF-YP3qvyf9juzP5men6enn86-vycP2XDluEr0he-vVjT0E2rTO3jb_xS_GkA-c |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+and+pharmacological+properties+of+4%285%29-%282-ethyl-2%2C3-dihydro-2+silainden-2-yl%29imidazole%2C+a+silicon+analogue+of+atipamezole&rft.jtitle=European+journal+of+medicinal+chemistry&rft.au=Heinonen%2C+P&rft.au=Sipil%C3%A4%2C+H&rft.au=Neuvonen%2C+K&rft.au=L%C3%B6nnberg%2C+H&rft.date=1996&rft.pub=Elsevier+Masson+SAS&rft.issn=0223-5234&rft.eissn=1768-3254&rft.volume=31&rft.issue=9&rft.spage=725&rft.epage=729&rft_id=info:doi/10.1016%2F0223-5234%2896%2985882-X&rft.externalDocID=022352349685882X |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0223-5234&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0223-5234&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0223-5234&client=summon |